The European Patent Office (EPO) has published patent application EP4004028A1, titled 'RELAXIN ANALOGS AND METHODS OF USING THE SAME', filed by Eli Lilly and Company. The publication date is March 11, 2026, and it covers various European designated states.

This publication serves as a notice of the patent application's existence and details. Companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in drug development and intellectual property, should note this publication. No immediate compliance actions are required as this is a patent publication, not a regulatory rule or enforcement action.